We've Moved! Visit our NEW FORUM to join the latest discussions. This is an archive of our previous conversations...

You can find the login page for the old forum here.
CHATPRIVACYDONATELOGINREGISTER
DMT-Nexus
FAQWIKIHEALTH & SAFETYARTATTITUDEACTIVE TOPICS
Recommended approach of senior JH psychedelic researcher for therapeutic use of psychedelics Options
 
Bancopuma
#1 Posted : 1/19/2018 3:24:15 PM

DMT-Nexus member

Senior Member

Posts: 2147
Joined: 09-May-2009
Last visit: 24-Mar-2024
Location: the shire, England
This is the approach described for therapeutic psilocybin sessions in particular recommended by senior Johns Hopkins psychedelic therapist Dr William Richards. Recommended setting is lying down on a cosy sofa (a bed will also do) in a nice cosy room with dim lighting, wearing eyeshades to facilitate an internal experience (I recommend some decent comfortable ones with hollow bits for the eyes), with a carefully selected playlist of instrumental music (avoid human vocals), so as to be comfortable and focus inwardly.

The recommended approach for psychotherapeutic use of psilocybin (from The Trip Treatment, linked below):

Quote:
"The “same force that takes you deep within will, of its own impetus, return you safely to the everyday world,” the manual offers at one point. Guides are instructed to remind subjects that they’ll never be left alone and not to worry about their bodies while journeying, since the guides will keep an eye on them. If you feel like you’re “dying, melting, dissolving, exploding, going crazy etc.—go ahead,” embrace it: “Climb staircases, open doors, explore paths, fly over landscapes.” And if you confront anything frightening, “look the monster in the eye and move towards it. . . . Dig in your heels; ask, ‘What are you doing in my mind?’ Or, ‘What can I learn from you?’ Look for the darkest corner in the basement, and shine your light there.” This training may help explain why the darker experiences that sometimes accompany the recreational use of psychedelics have not surfaced in the N.Y.U. and Hopkins trials."


https://www.newyorker.co...015/02/09/trip-treatment

A relevant paper published by the Johns Hopkins psilocybin research team that may be of interest:

Johnson, M.W., Richards, W.A. & Griffiths, R.R. 2008. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology, 22, (6), 603-620.

http://www.csp.org/psilo...llucinogenSafety2008.pdf

Spotify also has some of the playlists being used in clinical settings (the Imperial psilocybin playlist is "psilodep2" on Spotify, highly recommended):

https://open.spotify.com...t/6eD2isTqIlgmoywT4ie3LR
https://open.spotify.com...t/5KWf8H2pM0tlVd7niMtqeU
https://open.spotify.com...t/5JsBfRNFl5ryA6Q5sLOHyx
 

Live plants. Sustainable, ethically sourced, native American owned.
 
 
Users browsing this forum
Guest

DMT-Nexus theme created by The Traveler
This page was generated in 0.010 seconds.